Defence Therapeutics Stock Technical Analysis
| DTCFF Stock | USD 0.46 0.02 4.55% |
As of the 9th of February, Defence Therapeutics shows the Mean Deviation of 3.96, standard deviation of 5.33, and Variance of 28.4. Defence Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Defence Therapeutics, which can be compared to its peers. Please confirm Defence Therapeutics variance, as well as the relationship between the maximum drawdown and skewness to decide if Defence Therapeutics is priced favorably, providing market reflects its regular price of 0.46 per share. As Defence Therapeutics is a penny stock we also recommend to verify its jensen alpha numbers.
Defence Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Defence, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DefenceDefence |
Defence Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Defence Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Defence Therapeutics.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Defence Therapeutics on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Defence Therapeutics or generate 0.0% return on investment in Defence Therapeutics over 90 days. Defence Therapeutics is related to or competes with Sernova Corp, Cynata Therapeutics, Microbix Biosystems, Starpharma Holdings, Celyad Oncology, and Finch Therapeutics. Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biologicalbiosimilar ther... More
Defence Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Defence Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Defence Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 28.04 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 10.2 |
Defence Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Defence Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Defence Therapeutics' standard deviation. In reality, there are many statistical measures that can use Defence Therapeutics historical prices to predict the future Defence Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.44) |
Defence Therapeutics February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.43) | |||
| Mean Deviation | 3.96 | |||
| Coefficient Of Variation | (2,113) | |||
| Standard Deviation | 5.33 | |||
| Variance | 28.4 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.44) | |||
| Maximum Drawdown | 28.04 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 10.2 | |||
| Skewness | 0.3306 | |||
| Kurtosis | 0.6846 |
Defence Therapeutics Backtested Returns
Defence Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0522, which denotes the company had a -0.0522 % return per unit of risk over the last 3 months. Defence Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Defence Therapeutics' Mean Deviation of 3.96, standard deviation of 5.33, and Variance of 28.4 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.59, which means possible diversification benefits within a given portfolio. As returns on the market increase, Defence Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Defence Therapeutics is expected to be smaller as well. At this point, Defence Therapeutics has a negative expected return of -0.27%. Please make sure to confirm Defence Therapeutics' variance, skewness, price action indicator, as well as the relationship between the total risk alpha and rate of daily change , to decide if Defence Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.21 |
Weak predictability
Defence Therapeutics has weak predictability. Overlapping area represents the amount of predictability between Defence Therapeutics time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Defence Therapeutics price movement. The serial correlation of 0.21 indicates that over 21.0% of current Defence Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Defence Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Defence Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Defence Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Defence Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Defence Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Defence Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Defence Therapeutics price pattern first instead of the macroeconomic environment surrounding Defence Therapeutics. By analyzing Defence Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Defence Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Defence Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Defence Therapeutics February 9, 2026 Technical Indicators
Most technical analysis of Defence help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Defence from various momentum indicators to cycle indicators. When you analyze Defence charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.43) | |||
| Mean Deviation | 3.96 | |||
| Coefficient Of Variation | (2,113) | |||
| Standard Deviation | 5.33 | |||
| Variance | 28.4 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.44) | |||
| Maximum Drawdown | 28.04 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 10.2 | |||
| Skewness | 0.3306 | |||
| Kurtosis | 0.6846 |
Defence Therapeutics February 9, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Defence stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.05 | ||
| Day Median Price | 0.46 | ||
| Day Typical Price | 0.46 | ||
| Price Action Indicator | 0.01 |
Complementary Tools for Defence OTC Stock analysis
When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |